The Hidden Premium: Why Indian Investors Overpay for US Index Exposure — And How to Stop

There is a post doing the rounds from Akshat Shrivastava making a blunt claim: if you are an Indian investing in US markets through Indian funds, you are paying roughly a 20% premium. Something worth 100 costs you 120. The underlying can rise and you can still lose money.

The claim is correct, almost nobody is teaching it, and the current numbers are worse than the tweet suggests.

But it is not a flat 20% toll. A toll would be predictable and easy to price in. What Indian investors actually face is a volatile, mean-reverting spread that widens precisely when US markets are in the news — and then collapses months later, taking real capital with it. Here is the mechanism, the current data, the three routes out, and the costs the "just buy directly" advice usually omits.

Part 1: Where the Premium Comes From

It is not a fee and it is not greed. It is a broken arbitrage, and the break is regulatory.

SEBI and the RBI cap what the entire Indian mutual fund industry may hold overseas: ~USD 7 billion in aggregate, with ~USD 1 billion ring-fenced for investments into overseas ETFs. These are industry-wide limits, so when the bucket fills, every fund house hits the wall simultaneously.

An ETF's price normally tracks NAV because of creation and redemption: if the ETF trades above the value of its holdings, an authorised participant creates new units at NAV, sells them into the market at the higher price, and that selling drags the price back to fair value. The arbitrage is the repair mechanism.

When the overseas limit is exhausted, the fund house cannot buy more foreign stock, so it suspends creation of new units. The repair is switched off. What remains on the exchange is a fixed supply of units meeting unlimited demand.

Once creation is suspended, you are no longer buying the Nasdaq. You are buying a queue position from someone who got in before the queue closed.

Part 2: The Receipts

This is measurable daily, because fund houses must publish an iNAV — a live estimate of what one unit is genuinely worth — alongside the market price.

The four US ETFs on 29 July 2026

ETF	NAV (₹)	Price (₹)	Premium	52-wk avg
Motilal Oswal Nasdaq 100 (MON100)	254.32	315.36	24.0%	9.0%
Mirae Asset NYSE FANG+	154.79	191.34	23.6%	19.8%
Mirae Asset S&P 500 Top 50	62.90	77.37	23.0%	19.4%
Motilal Oswal Nasdaq Q50	114.64	140.71	22.7%	12.7%

Read the first two columns literally: ₹315.36 bought you ₹254.32 of Nasdaq 100. About ₹61 per unit bought nothing at all. All four sat in a tight 22–24% band, each above its own 52-week average.

By 12 August 2026 they had already repriced — MON100 to 19.5%, Mirae S&P 500 Top 50 to 20.3%, Nippon's Hang Seng BeES down to 4.9%. MON100's 52-week range tells the story on its own: −3.0% to +27.7%. Same fund, same index, a 31-point spread in what you pay, decided entirely by whether a regulatory valve was open on the day you clicked buy.

The week the premium hid a crash

Between 22 and 29 July 2026, MON100's NAV fell 7.0% in rupee terms — but its exchange price fell only 2.5%. The premium widened from 18.3% to 24% to absorb the gap.

Holders opened their app that week and saw a mild dip. The assets underneath them had dropped nearly three times as far.

A widening premium does not protect you from a decline. It defers it, and enlarges it.

That 4.5% of apparent cushioning was not a gain. It was deferred pain stacked onto an already-stretched price, and it unwinds the moment the valve opens.

The shape of it

Across roughly June 2023 to June 2026, MON100 averaged a ~3.7% premium, with a median day near 0.7% and ~35% of days at or below NAV. Yet it also spiked to 20.4% (Jan 2025), ~20% (Apr 2025), 16.3% (Oct 2025) and a record 27.7% (Jun 2026) — each collapsing within weeks.

The 2026 episode was the most insidious: barely 1% above NAV in March, climbing every single month to 24% by late July. A sudden spike at least looks like a warning. A patient four-month grind looks like the fund going up — and on a price chart, that is exactly what it looks like. June and July buyers were buying premium, not index, with no way to tell from the chart.

The average is not the risk. The distribution is. A 3.7% average sounds survivable, but the days retail actually buys — when US tech is euphoric and subscriptions have just been suspended — are disproportionately the 20%+ days. You do not get the average. You get the day you clicked.

Which means your return depends on two independent things: whether the index rises, and whether Indian regulatory scarcity persists at the same intensity when you exit. The second bet is structurally biased against you — caps are designed to be revisited, so every headline about SEBI raising overseas limits is mechanically a headline about your premium being destroyed. You are short the reform you would otherwise want, and paid nothing for the risk.

Part 3: Right About the Asset, Wrong About the Money

An investor put ₹1,00,000 into the Mirae Asset NYSE FANG+ ETF on 19 April 2024 at ₹97.10 — a 26.3% premium. Over the next ten weeks the underlying basket gained 21.4%. By 28 June 2024, price and NAV had converged and the position was worth about ₹97,189.

Underlying: +21.4%. Investor: −2.8%. A 24-point gap, on the correct call, in ten weeks.

And the premium is not merely an entry cost you can hold through — you also have to sell. Your realised return is index return + (exit premium − entry premium) − costs. Most people only ever look at the first term.

Part 4: The 20% Premium Is Not the 20% TCS

Confusing these two is the single most common reason Indians avoid the direct route — and it pushes them into the worse one.

	ETF premium to NAV	TCS on LRS remittance
Who receives it	The seller on the other side of your trade	The government, credited to your PAN
Do you get it back?	No. Permanently gone.	Yes. Adjustable against tax / refundable on filing your ITR
Threshold	None — from the first rupee	Only above ₹10 lakh of LRS remittances in a financial year

The TCS is a cash-flow cost — you lend the government money until you file. The premium is a permanent, unrecoverable one. People flee the refundable cost and walk into the real one. (The overall LRS cap is USD 250,000 per person per financial year.)

Part 5: The Three Routes

Route A — Indian ETF on NSE/BSE

Premium risk is severe and unpredictable (−3% to +27.7% in one year). Expense ratio ~0.58%–0.78%. Rupee-denominated, no LRS paperwork, no US estate tax exposure. Buyable even when FoFs are shut — which is exactly why the premium forms. Only sensible when you have checked the iNAV and the premium is near zero or negative. Never buy this blind.

Route B — International Fund of Fund (FoF) / index fund

No premium risk at all — you transact at the declared end-of-day NAV, by construction. SIP-able, no LRS usage, no Schedule FA, no US estate tax. Slightly higher total expense from fund-of-fund layering.

The catch: when the cap is exhausted these schemes suspend fresh lump sums, switch-ins and new SIP/STP registrations. This is now the normal state, not an occasional event. Nippon India suspended from 21 April 2026, Axis from 6 May 2026, PGIM closed three funds from 8 August 2026, Edelweiss six from 12 August 2026 — roughly 28 schemes frozen to new money by mid-August 2026. That forced closure is what pushes the crowd into Route A at a premium.

Reopenings are also easy to misread. Invesco resumed existing SIPs in three of its four global funds from 18 August 2026 — new registrations and lump sums stayed shut. Headroom appears when other investors redeem, not because the cap was raised. "Fund reopens" rarely means "you can invest."

Route C — Direct US brokerage via LRS

No premium, ever. QQQ, VOO and SPY trade in a deep, properly arbitraged market whose authorised participants are not blocked by anyone's regulatory cap. Expense ratios are dramatically lower — QQQ ~0.20%, VOO ~0.03% against 0.58%+ domestically — and you get the full universe rather than the handful of schemes an AMC chose to launch.

The costs you must actually count are the forex conversion spread (the biggest hidden cost of this route, and the one that varies most by platform), wire fees, LRS Form A2 paperwork, the refundable 20% TCS above ₹10 lakh, consumption of your USD 250,000 annual LRS cap, and mandatory Schedule FA disclosure of foreign assets in your ITR — non-filing carries penalties under the Black Money Act.

The platforms Indians can actually use

There is a structural distinction here that matters more than the headline fees, and it is the same "middle agent" question the original post raises:

• Direct broker — you hold an account in your own name at a US-regulated broker.
• App / aggregator — an Indian-facing app routes your order to a US clearing partner (usually DriveWealth or Alpaca). Convenient, and there is an extra intermediary earning a margin, most of it inside the FX spread.

Platform	Structure	FX markup (published)	Brokerage	Notes
Interactive Brokers (IBKR)	Direct account, SEC/FINRA	~1–5 paise per USD (near-interbank, small per-conversion minimum)	From ~$0.0035/share	170+ markets including LSE, so UCITS ETFs are reachable. You handle LRS paperwork yourself. Best above roughly ₹25 lakh/year.
INDmoney	App	~1%–1.5% (own disclosure: 0.5%–1.2%)	Zero	US stock SIPs, fractional from $1, 1,000+ securities. Withdrawal bundled into the spread.
Winvesta	App → Alpaca	~1%	No per-trade brokerage	11,000+ securities, fractional from $1, FCA + SIPC coverage. ~$10 withdrawal.
Vested Finance	App → DriveWealth	~1.5%–2% (own blog claims 0.75%–1%)	Basic 0.25% capped $35; Premium plan lowers to 0.15%	Fractional from $1. ~$11 withdrawal. Zerodha's US-investing tie-up routes here.
Borderless (ex-Stockal)	App → DriveWealth	~0.99%	$0 basic, fees on Pro tiers	Same clearing infrastructure as Vested.

Treat every one of those FX figures sceptically. Nearly all published comparisons are written by one of the competitors, and the numbers conflict — Vested's own blog puts its markup near 0.75–1% while rival write-ups put it at 1.5–2%. The direction all sources agree on is what matters: IBKR's conversion cost is an order of magnitude below the app platforms', which cluster around 1–2% per conversion. On a ₹10 lakh remittance that difference is roughly ₹5,000–₹15,000 — each way. Verify by comparing the rate you were actually given against the interbank rate on the day.

Two further points before you choose:

• Platform risk is real. Groww exited US stocks in late 2023, requiring users to sell or transfer holdings. Cross-border compliance is expensive, and platforms treating it as a side feature can withdraw it. Prefer providers whose core business this is, and check the transfer-out path before you need it.
• Bank and broker "global investing" desks (HDFC Securities, ICICI Direct, Kotak, Axis) mostly resell one of the above or route to a US partner. Convenient if you already bank there — ask which clearing broker sits underneath and what the all-in FX markup is, because that is where the cost hides.

Part 6: The Catch on the Direct Route

If the premium is the cost nobody warns you about domestically, US estate tax is its mirror image abroad.

As an Indian resident holding US-situs assets you are a non-resident alien for US estate tax purposes. Your exemption is USD 60,000 — not the ~USD 13 million a US citizen gets — and assets above it can be taxed at rates climbing to 40%. US-listed shares and US-domiciled ETFs (AAPL, NVDA, QQQ, VOO, SPY) are US-situs. India has no estate tax treaty with the United States; the DTAA covers income tax and does not help here.

A ₹1 crore US portfolio is roughly USD 115,000 of US-situs assets — around USD 55,000 above the exemption. Routes A and B carry zero such exposure, because you own an Indian mutual fund unit, not a US share.

Serious long-term direct investors handle this, commonly via Irish-domiciled UCITS ETFs (not US-situs, and taxed at 15% on US dividends under the Ireland–US treaty rather than 25% for Indian residents) — one concrete reason IBKR's access to the LSE matters. Whether a given UCITS ETF is available to you depends on your broker; confirm before assuming.

The honest summary: both routes carry a cost that is invisible at purchase. One shows up the day you buy. The other shows up the day your family needs the money.

Part 7: What To Actually Do

The 60-second check before any international ETF purchase

1. Find the scheme's iNAV (fund houses publish it live; exchanges carry an iNAV symbol).
2. Compare against the live market price and compute (Price − iNAV) / iNAV × 100.
3. Above ~2%: do not buy. Above 10%: you are speculating on scarcity, not investing in an index. Below 0%: a genuine discount, which does happen.

Zerodha now shows an iNAV nudge in the Kite order window (launched 21 April 2026) warning when an ETF is trading away from fair value. If your broker offers something similar, do not click past it. This one habit would have saved the April 2024 FANG+ investor their entire loss.

Choosing a route

• Under ₹10 lakh a year, want simplicity: use an international FoF/index fund when open. NAV-priced, SIP-able, no Schedule FA, no estate tax. Do not chase the ETF when the FoF is closed — that closure is the warning, not the invitation.
• Building a serious long-term US allocation: the direct route is genuinely cheaper. Pick the platform on FX markup rather than app polish, budget for the spread, file Schedule FA, and settle the estate-tax question before the portfolio is large.
• Already holding at a premium: do not panic-sell into a collapse. Know your entry premium, stop adding at elevated ones, and redirect new money to a NAV-priced or direct route.
• Everyone: stop treating "US exposure" as one line item. Same index, four products, four different answers on cost, tax, liquidity and succession.

Part 8: Why You Have to Track This Yourself

The original post's sharpest observation is that no one is coaching you on this — and that is structural. Your AMC's factsheet reports NAV-based returns: the fund's honest performance, and not yours if you bought at a 24% premium. Your broker's app shows the price you paid and the price today, never the premium embedded in either. Nobody in the chain is positioned to tell you that ₹1,00,000 bought ₹80,000 of Nasdaq — the AMC did not sell you those units, another investor did.

So the reconciliation is yours, and it has to span wrappers: your true blended cost of US exposure across the NSE-listed ETF, the FoF and the direct holding; your real XIRR on your own cash flows (the only number that includes the premium you paid); whether you are accidentally holding the same index three ways; and how much of your net worth is US-situs.

That last one is only answerable if direct holdings stay separate from domestic wrappers instead of collapsing into one "US Equity" bucket. Agni Folio tracks Indian and international holdings side by side, runs every currency conversion on the backend against real exchange rates, computes true XIRR on your actual cash flows, and keeps a domestically-wrapped position distinct from a directly-held one — so both the duplication and the situs exposure stay visible.

You can also ask it directly through the built-in AI assistant, or connect Agni Folio to your own AI via MCP: "how much US exposure do I hold, through which wrappers, and what did I actually pay for it?"

The Short Version

• The premium is real but not a flat 20% — MON100 ranged from a 3% discount to a 27.7% premium in one year, and sat at 24% on 29 July 2026.
• It exists because SEBI/RBI caps (~$7bn overall, ~$1bn for ETFs) force AMCs to suspend unit creation, switching off the arbitrage that pins price to NAV.
• In late July 2026 the premium hid a 7% NAV fall behind a 2.5% price fall. Cushioning is deferred pain, not protection.
• Documented loss: a FANG+ buyer on 19 Apr 2024 saw the underlying gain 21.4% while ₹1,00,000 became ₹97,189.
• The 20% premium is permanent; the 20% TCS is refundable. Do not confuse them.
• FoFs carry no premium risk — use them when open. ~28 schemes were frozen by mid-Aug 2026, and that closure is what creates the ETF premium.
• Direct route: IBKR's FX markup is ~1–5 paise/USD versus ~1–2% at app platforms — worth ₹5,000–₹15,000 per ₹10 lakh, each way. But it adds Schedule FA and US estate tax above USD 60,000 with no India–US treaty.
• Check the iNAV before you click. Above 2%, wait.

None of this makes international investing a bad idea — global diversification is sound and Indian investors should have it. The argument is narrower: the wrapper is not a detail, and the gap between the best and worst choice compounds into a number large enough to matter for the rest of your life.

Informational summary of publicly reported data and published statutory rates, not investment or tax advice. Premium and fee figures move constantly and platform pricing is largely self-reported by competitors — verify the live iNAV and your actual FX rate before acting. Confirm your own position with a qualified professional.

Track what you actually paid for your US exposure, across every wrapper — get started with Agni Folio.